A comprehensive portal site for 
2019年8月13日（火）～2019年8月15日（木）は、夏季休業とさせていただきます。
この期間中にお受けしたお問い合せ・ご相談の申込みについては、休業明けに対応させていただきます。
何卒ご了承のほどお願いいたします。
お知らせ
- 2018.03.01
- Opend the New our homepage!
What is MEDISO
MEDISO provides support for business ventures, academia,
and individuals intending to put into practical use medicines,
medical devices, and regenerative medicinal products.
Click here for further details.
About the Medical Innovation Support Office
The medical innovation support office matches medical venture companies and academic institutions facing challenges in the practical application of medical products and devices for specialists* who provide detailed consultation and support for solving problems at each stage from research and development to practical use, as well as insurance coverage at clinical sites, while looking ahead to the overall comprehensive advances and dissemination into the global market.
* Specialists in each field provide support for the response to laws and regulations, marketing, business planning, fund rasing, management strategy, intellectual property management, and international development, etc.
This website is operated by Mitsubishi Research Institute, Inc., as a trustee under instructions from the Economic Affairs Division, Health Policy Bureau, and Ministry of Health, Labour and Welfare as a part of the total support for the medical ventures program sponsored by the Ministry of Health, Labour and Welfare.
Support targets
Ventures, academic institutions, and individuals aiming to put into practical use the medicines, medical devices, regenerative medicinal products, and novel drug-discovery technologies or medical materials subject to the Pharmaceuticals and Medical Devices Law.
Details of support
MEDISO provides support for the practical application of medicines, medical devices, regenerative medicinal products, and other products subject to the Pharmaceuticals and Medical Devices Law.
That support includes business planning, financing, advice on laws and regulations, and other assistance as required.
- ●Support method：We provide support via phones, e-mail, and meetings.
- ●Support source：Support is provided in cooperation with experts in R&D, consultants in pharmaceutical affairs, and experts from related organizations including the Ministry of Health, Labour and Welfare.
- ●Remarks：Consultation and support services are free of charge.
Click here for inquiries and consultation requestsSpecialists Introduction
We will introduce registered specialists
(updated as necessary).
Tamaki Nara
Director, Olvis Planning Co., Ltd.
Main specialty areas
- medicines
- medical devices
- regenerative medicine products
Specialized support fields
- Regulatory compliance
- Marketing
- Business planning
- Funding
- Business operation systems
- Specialized support fields
She graduated from the Department of English Literature, School of Humanities, Kansei Gakuin University (English and Sociology) and graduated from Business Breakthrough University (Management and Marketing). She worked in the international department of a city bank, lived in the UK, and then worked for a leading precision equipment maker. She devoted almost five years to making plans for new project and management for digital equipment and then devoted almost ten years to providing planning and development and making plans for management for new field products in medical devices and healthcare (medical IT) projects. Especially during this period, she felt great significance in establishing a collaborative development system with medical-based researchers while experiencing the bodily sensations of strength, weakness, joy, a feeling of achievement, and challenges in developing new business in medical devices and healthcare in companies. This experience made her give guidance about medical device development and open innovation establishment. Since then about four years have passed and her role has not changed.
Paper: Cancer and Chemotherapy, 2015, joint work
Title: Development of Support System for Breast Cancer Patients,
Managing Side Effects Through an Internet-based System, etc.
Lecture:
A Symposium for innovation through collaboration between industry and academia in Waseda University and Kobe University
Collaboration Between Industry and Academia in the Development of Medical Devices in Our Company—from an experience of accepting an internship of a doctor from the School of Medicine, Kobe University.
Koji Yoshida
Representative Director, Luminov Inc.
Main specialty areas
- medical devices
Specialized support fields
- Regulatory compliance
- Marketing
- Business planning
- Funding
- Business operation systems
- Specialized support fields
After graduation from university, he was involved in marketing at the world's biggest foreign-affiliated manufacturer of artificial joint for 20 years. After he experienced the role of a leader of unit with a budget of 15 billion yen, he launched his own business in 2014. He established Luminov Inc., which specializes in the development, manufacturing, and sales of medical devices. In 2017, he planned a medical-industrial cooperation event on consignment from a public entity. He held workshops for companies who entered this industry from different industries. Products newly developed at these workshops were highly regarded, having won a second prize in an international event associated with medical care devices. Furthermore, the unique strategy for developing medical devices that uses workshops and medical care products originated from these workshops were frequently quoted in the media.
Masashi Matsunaga
Oxentia Ltd Senior Consultant
Main specialty areas
- medicines
- medical devices
- regenerative medicine products
Specialized support fields
- Marketing
- Business planning
- Funding
- Business operation systems
Masashi Matsunaga is an experienced international business development professional working in the life sciences and chemical fields for more than 20 years. He has created invaluable personal networks in the Japanese and oversea business communities as well as government and academic societies. He also has team management skills that he developed diverse international teams both in large and small companies. Always Masashi is challengeable for new innovative businesses with creating new value to the market with understanding the key value of the technology being able to present to different level of peoples.
Satoshi Konishi
President and Representative, KHE Consulting and KHE International Patent Office
Main specialty areas
- medicines
- medical devices
- regenerative medicine products
Specialized support fields
- Regulatory compliance
- Marketing
- Business planning
- Funding
- Business operation systems
- Specialized support fields
He graduated with a doctoral degree in engineering from the Graduate School of Engineering Science, Osaka University. He worked on research and development and the business development of medical devices in multiple companies, including Toshiba Corporation and Schlumberger Limited. He served as the director of the research institute and the project leader and promoted collaborative research and collaborative business with enterprises and universities in Japan and overseas. After his retirement, he established KHE Consulting and the KHE International Patent Office. He provides guidance on technology and regulatory to healthcare-related venture companies in Japan and overseas, support for management and commercializing, business liaison services in Japan and overseas, incubations based on intellectual property, and patent applications and right acquisitions of patents. He sponsors seminars on medical device industries, intellectual property rights, and international technology standards.
He was registered as a patent attorney, certified as a foreign certified vocational training instructor by the former Ministry of Labor, and registered as an international business partner in Alberta, Canada. Other than that, he is serving as a counselor on public support for management.
Kiyoshi Kanazawa
Janssen Pharmaceutical K.K.
Main specialty areas
- medicines
Specialized support fields
- Regulatory compliance
He graduated with a doctoral degree in science and engineering from the Graduate School, Tokyo Institute of Technology. He has worked at several pharmaceutical companies, during which he had engaged in drug discovery research as a pharmacological researcher (at Japanese-affiliated companies and venture companies for eight years) and after that he has been involved in portfolio management (as his current position at a foreign-affiliated company for five years). At venture companies, he contributed to concluding some types of contracts, contracts of collaborative research with pharmaceutical companies, and contracts for collaborative development and research with university hospitals as a person responsible for pharmacology. He is willing to contribute to formulation of study plans based on medical needs at the worldwide scale, not on a domestic scale, in this project. He has experience in areas of cancer, auto-immune disease, respiratory disease, and chronic kidney disease.
Introduction of measures implemented by public institutions
We will describe the measures from public institutions for pharmaceutical companies,
medical device companies, companies manufacturing regenerative medicinal products, and venture companies.
- The Ministry of Health, Labour and Welfare／
- Pharmaceuticals and Medical Devices Agency (PMDA)／
- Japan Agency for Medical Research and Development (AMED)／
- Cabinet Office／
- Ministry of Economy, Trade and Industry／
- Ministry of Internal Affairs and Communications／
- Small and Medium Enterprise Agency／
- Organization for Small & Medium Enterprises and Regional Innovation, Japan／
- Union of Kansai Governments／
- New Energy and Industrial Technology Development Organization (NEDO)／
- Life Science Innovation Network Japan, Inc. (LINK-J)／
- Japan Science and Technology Agency (JST)／
- Japan External Trade Organization (JETRO)／
- INCJ, Ltd.／
- Osaka Prefecture／
- Tokyo Metropolis／
- Kanagawa Prefecture／
- National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
